Header

Sub Navigation

  Close Menu

Vaccine Information and Planning


Scroll to the bottom to use Google Translate
to view in other languages.
Deslice hasta la parte inferior para usar
el Traductor de Google y ver en otros idiomas.

COVID-19 Vaccination in Indiana

Anyone age 6 months and older may now receive the safe, effective and free COVID-19 vaccine. The Centers for Disease Control and Prevention (CDC) recently endorsed vaccination for ages 6 months through 5 years for Moderna and Pfizer. No appointment is necessary while we update our registration system. Please check the vaccination site details for registration information. Click here to register or call 211 (866-211-9966) if you do not have access to a computer or need assistance.

Sites that offer vaccine to a pediatric age group are marked with a pin on the site map, with more details on the site’s specific pop-up information. Zoom out on the map to expand your search. If you don’t see the vaccination site you’re looking for, it’s possible that all appointments are full.

In the Indiana Department of Health’s (IDOH’s) registration system, when you enter a ZIP code to search for a vaccination site, you will find several vaccination locations near you. Scroll to see the site you selected on the map. The site’s information will include which vaccine is likely available at the site. You can click “Find Next Available Appointment” to get to the soonest date and time.

You may want to verify availability in advance by calling the site or contact your healthcare provider. Call Indiana 211 (866-211-9966) if you would like to make an appointment to receive the Moderna vaccine for ages 6-11 years old.

The Center for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) reviewed the U.S. Food and Drug Administration’s (FDA’s) amended Emergency Use Authorization of COVID-19 of the vaccines.

The CDC has posted a COVID-19 vaccination schedule, which includes booster doses and additional doses for people who are moderately to severely immunocompromised, and vaccine recommendations for children and teens.

Based on CDC recommendations, IDOH supports the administration of booster doses to individuals who attest to meeting CDC guidelines. Eligible individuals may choose which vaccine they receive as a booster dose (Español). Any vaccination site can administer a booster dose.

A booster dose is not the same as the third additional dose of Pfizer or Moderna vaccine due to an individual’s immunocompromised status when getting another dose of the vaccine can sometimes help them build more protection against the disease.

The state Department of Health, following guidance from the CDC and ACIP, recommends that people who are moderately to severely immunocompromised receive an additional dose of the mRNA (Pfizer or Moderna) COVID-19 vaccine. People should talk to their healthcare providers about their medical condition and whether getting an additional dose is appropriate for them.

Please note that the FDA has also issued a statement limiting the authorized use of Johnson & Johnson (Janssen) vaccine to anyone 18 years of age and older if other approved vaccines are not available or clinically appropriate, and they would otherwise not get vaccinated.

Check the CDC website for more vaccine information.

Already received the vaccine? Make sure you sign up for the v-safe after-vaccination health checker.

Get your vaccination certificate

If you’ve been vaccinated, connect with the Indiana Vaccination Portal to get your vaccination certificate using Access Indiana.
Click here then on the tile "Indiana Vaccination Portal"

Have a question about COVID-19 vaccine? Search our Frequently Asked Questions.

To filter the FAQ lists below, please type in a keyword or phrase in the search field. Once you start typing the lists below will show only relevant results.

Vaccine Safety

Vaccine Scheduling and Registration

Vaccine Administration

Schedule Second Dose

Your Vaccination

Other Vaccine Questions


About the vaccine

Pfizer-BioNTech, Moderna and Johnson & Johnson vaccines have received Emergency Use Authorization (EUA), and additional vaccines are being developed by other manufacturers. The EUA process has allowed for clinical trials and manufacturing to occur simultaneously, while still allowing for rigorous testing to determine how safe and effective it is.

  1. Safety is top priority.
    The first goal is to focus on the safety of the vaccine and determining how effective it is. Before any vaccine is released, it must first complete three phases of clinical trials to study its effect on thousands of diverse study participants. Once that study is done, the pharmaceutical company submits the results for Emergency Use Authorization (EUA) from the U.S. FDA. This is a way to make important health breakthroughs available to the public quickly.

    The vaccine is then reviewed by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP). ACIP is a federal advisory committee of medical and public health experts who develop recommendations on the use of vaccines in the U.S. public.

    The next step before the vaccine is available is for the Indiana Department of Health’s Vaccine Allocation Plan Development Advisory Group to make final recommendations on the ethical and equitable allocation of a limited COVID-19 vaccine.

    2. For primary and booster vaccination, people should receive an age-appropriate mRNA vaccine (Pfizer or Moderna). The Johnson & Johnson vaccine is authorized for anyone age 18 and older if no other approved vaccine is available because of a slightly increased risk for a rare but serious blood clotting disorder. Most people who developed these blood clots and low levels of platelets were females ages 18 through 49 years. Symptoms typically began one to two weeks following vaccination, and no cases occurred more than 30 days following vaccination. The chance of this occurring is remote. You should seek medical attention right away if you have any of the following symptoms after receiving Johnson & Johnson (Janssen) COVID-19 vaccine:

  • Severe or persistent headaches or blurred vision
  • Shortness of breath
  • Chest pain
  • Leg swelling
  • Persistent abdominal pain
  • Easy bruising or tiny blood spots under the skin beyond the site of the injection
  • V-Safe Information Sheet (English) (Spanish) (Chinese) (Korean) (Vietnamese)

  • Vaccine is available near you. The Pfizer vaccine is available for anyone age 5 and older, and the Moderna vaccine is available for anyone age 18 and older. The Johnson & Johnson vaccine is authorized for anyone age 18 and older if no other approved vaccine is available.

    Vaccines by Pfizer ( click here for Spanish version ), Moderna (click here for Spanish version) and Johnson & Johnson (click here for Spanish version) are now available. COVID-19 vaccination is recommended for all people 5 years and older, including people who are pregnant, breastfeeding, trying to get pregnant now, or might become pregnant i<p>n the future. Evidence about the safety and effectiveness of COVID-19 vaccination during pregnancy has been growing. These data suggest that the benefits of receiving a COVID-19 vaccine outweigh any known or potential risks of vaccination during pregnancy.

    Already received the vaccine? Make sure you’re on the Centers for Disease Control and Prevention’s v-safe after vaccination health checker.

  • Vaccine is free. Your insurance may be billed an administration fee but patients will not be charged.

  • Based on evolving evidence, CDC recommends fully vaccinated people get tested immediately if they have symptoms or 5 days after close contact with a person with suspected or confirmed COVID-19.

    People are considered fully vaccinated:

    • 2 weeks after their second dose in a 2-dose series, such as the Pfizer or Moderna vaccines, or
    • 2 weeks after a single-dose vaccine, such as Johnson & Johnson’s Janssen vaccine

    The CDC has updated its quarantine guidelines. The following information outlines quarantine guidelines for people who have been exposed to COVID-19:

    If you are unvaccinated:

    • Stay home for 5 days. After that continue to wear a mask around others for 5 additional days.
    • If you can’t quarantine, you must wear a mask for 10 days.
    • Test on day 5 if possible.
    • If you develop symptoms, get a test and stay home.

    If you have NOT received a booster dose, and have completed the primary series of an mRNA vaccine (Pfizer or Moderna) 6 or more months ago or completed the primary series of the Johnson & Johnson vaccine 2 or more months ago:
    Stay home for 5 days. After that continue to wear a mask around others for 5 additional days.

    • If you can’t quarantine, you must wear a mask for 10 days.
    • Test on day 5 if possible.
    • If you develop symptoms, get a test and stay home.

    If you HAVE received a booster dose, or completed the primary series of an mRNA vaccine (Pfizer or Moderna) less than 6 months ago or completed the primary series of the Johnson & Johnson vaccine less than 2 months ago:

    • Wear a mask around others for 10 days.
    • Test on day 5, if possible.
    • If you develop symptoms, get a test and stay home.

    • Vaccine Information:

    Host a Community COVID-19 Vaccination and Testing Event

    Use your smartphone to tell CDC about any side effects after getting the COVID-19 vaccine. You’ll also get reminders if you need a second vaccine dose.

    vsafe

    Email Updates
    To sign up for updates or to access your subscriber preferences, please enter your contact information below.

    This site was last updated Jul 18, 2022 1:01 PM